Skip to main content
  • Book
  • © 1978

Biosynthetic Products for Cancer Chemotherapy

Volume 2

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (9 chapters)

  1. Front Matter

    Pages i-ix
  2. Introduction

    • George R. Pettit, Gordon M. Cragg
    Pages 1-9
  3. Higher Plant Terpenoids

    • George R. Pettit, Gordon M. Cragg
    Pages 11-43
  4. Higher Plant Steroids

    • George R. Pettit, Gordon M. Cragg
    Pages 45-59
  5. Higher Plant Lignans

    • George R. Pettit, Gordon M. Cragg
    Pages 61-63
  6. Quinones, Flavans, and Other Nonnitrogenous Higher Plant Products

    • George R. Pettit, Gordon M. Cragg
    Pages 65-68
  7. Higher Plant Alkaloids, Amides, and Ansa Macrolides

    • George R. Pettit, Gordon M. Cragg
    Pages 69-88
  8. Fungi and Other Lower Plant Biosynthetic Products

    • George R. Pettit, Gordon M. Cragg
    Pages 89-115
  9. Marine Invertebrate and Other Lower Animal Biosynthetic Products

    • George R. Pettit, Gordon M. Cragg
    Pages 117-120
  10. Marine Vertebrate and Other Higher Animal Biosynthetic Products

    • George R. Pettit, Gordon M. Cragg
    Pages 121-126
  11. Back Matter

    Pages 127-150

About this book

An overall view of the cancer problem and development of cancer chemothera­ 231 peutic biosynthetic products to February 1976 was presented in Volume 1. In the short time that has elapsed since the preparation of Volume 1, several very stimulating advances in application of biosynthetic cancer chemotherapeutic drugs in cancer treatment have been reported. At the May 1976 meeting (in Toronto) of the American Association for Cancer Research, a Sloan-Kettering research group summarized an improved treatment of human neuroblastoma using a combination of vincristine, cytoxan, trifluorothymidine, and papaverine. In the same period other clinical groups described significant advances in the cancer chemotherapeutic treatment of human breast cancer and oat cell carcinoma of the lung. Each of these newer advances in cancer treatment was based on combinations of biosynthetic and synthetic cancer chemotherapeutic drugs. Certainly, further examination of the antineoplastic biosynthetic agents summarized in this volume and the vast number yet to be discovered will eventually provide the means for controllil).g and/or curing the various types of human cancer.

Authors and Affiliations

  • Arizona State University, Tempe, USA

    George R. Pettit

  • University of Cape Town, South Africa

    Gordon M. Cragg

Bibliographic Information

  • Book Title: Biosynthetic Products for Cancer Chemotherapy

  • Book Subtitle: Volume 2

  • Authors: George R. Pettit, Gordon M. Cragg

  • DOI: https://doi.org/10.1007/978-1-4684-3018-9

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1978

  • Softcover ISBN: 978-1-4684-3020-2Published: 31 January 2013

  • eBook ISBN: 978-1-4684-3018-9Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: IX, 150

  • Topics: Pharmacology/Toxicology

Buy it now

Buying options

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access